Evidence map›Paper›PMID 24915566›Full record

ArticlePloS one2014

Evaluation physical characteristics and comparison antimicrobial and anti-inflammation potentials of dental root canal sealers containing hinokitiol in vitro.

Yin-Hua Shih, Dan-Jae Lin, Kuo-Wei Chang, Shih-Min Hsia, Shun-Yao Ko, Shyh-Yuan Lee, Shui-Sang Hsue, Tong-Hong Wang, Yi-Ling Chen, Tzong-Ming Shieh

Open access · goldAbstract readComparative StudyEvaluation Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Anticancer Properties of Eugenol: A Review.Molecules (Basel, Switzerland) · 2021
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Natural Antibacterial Reagents (Nanomaterials (Basel, Switzerland) · 2019
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Yin-Hua ShihInstitute of Oral Biology, School of Dentistry, National Yang-Ming University, Taipei, Taiwan.
Dan-Jae LinDepartment of Dental Hygiene, College of Health Care, China Medical University, Taichung, Taiwan.
Kuo-Wei ChangDepartment of Dentistry, School of Dentistry, National Yang-Ming University, Taipei, Taiwan; Department of Stomatology, Oral and Maxillofacial Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
Shih-Min HsiaSchool of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan.
Shun-Yao KoGraduate Institute of Medical Science, College of Health Science, Chang Jung Christian University, Tainan, Taiwan.
Shyh-Yuan LeeDepartment of Dentistry, School of Dentistry, National Yang-Ming University, Taipei, Taiwan.
Shui-Sang HsueDepartment of Oral Pathology, China Medical University Hospital, Taichung, Taiwan.
Tong-Hong WangTissue Bank, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan.
Yi-Ling ChenDepartment of Dental Hygiene, College of Health Care, China Medical University, Taichung, Taiwan.
Tzong-Ming ShiehDepartment of Dental Hygiene, College of Health Care, China Medical University, Taichung, Taiwan.
China Medical University · TWNational Yang Ming Chiao Tung University · TWChang Gung Memorial Hospital · TWChang Jung Christian University · TWChina Medical University Hospital · TWNational Yang Ming Chiao Tung University · TWTaipei Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hinokitiol displays potent antimicrobial activity. It has been used in toothpaste and oral-care gel to improve the oral lichen planus and reduce halitosis. The aim of this study was to evaluate the antimicrobial activity of 3 different dental root canal sealers with hinokitiol (sealers+H) and their physical and biological effects. AH Plus (epoxy amine resin-based, AH), Apexit Plus (calcium-hydroxide-based, AP), and Canals (zinc-oxide-eugenol-based, CA), were used in this study. The original AH and CA exhibited strong anti-methicillin-resistant Staphylococcus aureus (anti-MRSA) activity, but AP did not. The setting time, working time, flowability, film thickness, and solubility of each sealer+0.2%H complied with ISO 6876:2001. CA+0.2%H exhibited high cytotoxicity, but the others sealers+0.2%H did not. Because hinokitiol combined with Zn2+ in CA creates a synergistic effect. The physical tests of AP+0.5%-1%H complied with ISO 6876:2001, improved antimicrobial activity, inhibited inflammation genes cyclooxygenase-2 (COX-2) and hypoxia-inducible factor-1α (HIF-1α) mRNA in MG-63 cells and human gingival fibroblasts (HGF), and down-regulated lysyl oxidase (LOX) mRNA of HGF. In summary, AH and CA demonstrated strong antimicrobial activity, but AP did not. Application of hinokitiol increases AH anti-MRSA activity should less than 0.2% for keep well flowability. AP+0.5%-1% hinokitiol exhibited strong physical, antibacterial, and anti-inflammation potentials, and inhibited S. aureus abscess formation. Applying an appreciable proportion of hinokitiol to epoxy-amine-resin-based and calcium-hydroxide-based root canal sealers is warranted, but the enhanced cytotoxicity and synergistic effect must be considered.

Indexed as

Aggregatibacter actinomycetemcomitansAnti-Infective AgentsCells, CulturedCyclooxygenase 2FibroblastsHumansHypoxia-Inducible Factor 1, alpha SubunitMethicillin-Resistant Staphylococcus aureusMonoterpenesPit and Fissure SealantsProtein-Lysine 6-OxidaseRNA, MessengerRoot Canal Filling MaterialsStreptococcus mutansTropoloneAnti-Infective Agentsbeta-thujaplicinCyclooxygenase 2Hypoxia-Inducible Factor 1, alpha SubunitMonoterpenesPit and Fissure SealantsProtein-Lysine 6-OxidaseRNA, MessengerRoot Canal Filling MaterialsTropolone

Identifiers

PMID24915566
PMCPMC4051635
OpenAlexW1974755683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.